Want to join the conversation?
$XYL 2Q15 PR: FY15 Outlook: XYL continues to expect revenue of approx. $3.7Bil, decrease of 6-7% from FY14 results. Adjusted operating income expected to be $470-483MM, resulting in adjusted EPS of $1.82-1.87. Adjusted EPS growth in the range of 6-7% over comparable FY14 results. Projected restructuring and realignment costs of $20MM is unchanged.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?